Filter
1583
Text search:
drug
market
Featured
Recommendations
131
New Publications
465
Language
Document type
No document type
878
Studies & Reports
297
Guidelines
193
Strategic & Response Plan
87
Manuals
75
Fact sheets
22
Training Material
16
Situation Updates
7
Resource Platforms
5
Brochures
1
App
1
Infographics
1
Countries / Regions
India
80
Global
65
Kenya
61
Ethiopia
51
Uganda
48
Western and Central Europe
40
Ghana
37
Nigeria
36
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Sierra Leone
29
Zambia
26
Malawi
26
South Africa
25
Africa
25
Nepal
21
Tanzania
21
Philippines
20
Rwanda
18
Ukraine
17
Latin America and the Carribbean
17
Congo, Democratic Republic of
16
Zimbabwe
15
Cambodia
14
Asia
13
Namibia
12
South–East Asia Region
12
Eastern Europe
12
Indonesia
10
Venezuela
10
Senegal
9
Syria
9
Guinea
8
Brazil
8
Botswana
8
Lesotho
8
Mozambique
7
Burkina Faso
6
Cameroon
6
Thailand
6
China
6
Albania
6
Russia
6
Haiti
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Vietnam
5
South Sudan
4
Sudan
4
Colombia
4
Sri Lanka
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Germany
3
Benin
3
Peru
3
North Macedonia
3
Mexico
3
Middle East and North Africa
3
Laos
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Somalia
2
Pakistan
2
Jordan
2
Lebanon
2
Central African Republic
2
Argentina
2
Hungary
2
Libya
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Iran
2
Morocco
1
Iraq
1
Afghanistan
1
Papua New Guinea
1
Switzerland
1
Serbia
1
Bolivia
1
Madagascar
1
Chile
1
Fiji
1
Bhutan
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
101
Public Health
71
Key Resources
54
Pharmacy & Technologies
41
Women & Child Health
40
Capacity Building
13
Toolboxes
HIV
151
Mental Health
135
AMR
131
TB
104
Pharmacy
103
COVID-19
70
NTDs
41
Malaria
30
Planetary Health
28
Health Financing Toolbox
26
Conflict
25
Ebola & Marburg
23
Global Health Education
22
NCDs
22
Disability
18
Refugee
18
Caregiver
16
Rapid Response
13
Cholera
12
2.0 Rapid Response
7
Natural Hazards
6
Social Ethics
4
Polio
3
Specific Hazards
3
Strategic Overview
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i
...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use dru
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe
...
First Revised Edition
March 2000
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
World Drug Report 2018
-3-
